NCT05607979View on ClinicalTrials.gov

Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

December 15, 2022

Primary Completion Date

May 1, 2024

Study Completion Date

May 1, 2024

Conditions
Diabetic Foot Ulcer
Interventions
DRUG

Lavior Diabetic Wound Gel

Daily application of hydrogel treatment for 60 days.

DRUG

Smith & Nephew Solosite Gel Hydrogel Wound Dressing

Daily application of hydrogel treatment for 60 days.

Trial Locations (1)

33138

Baefoot Podiatry, Miami

Sponsors

Lead Sponsor

Lavior Pharma Inc.
All Listed Sponsors
lead

Lavior Pharma Inc.

INDUSTRY

NCT05607979 - Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds | Biotech Hunter | Biotech Hunter